| Maher Alchreiki, MD | |
|
216 W Walnut St, Danville, KY 40422-1858 | |
| (859) 239-5870 | |
| Not Available |
| Full Name | Maher Alchreiki |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 5 Years |
| Location | 216 W Walnut St, Danville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518251446 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mcdowell Home Health Agency | Danville, KY | Home health agency |
| Ephraim Mcdowell Regional Medical Center | Danville, KY | Hospital |
| The James B. Haggin Memorial Hospital | Harrodsburg, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ephraim Mcdowell Health Resource Inc | 7517876956 | 115 |
News Archive
Reuters examines the WHO's battle against the H1N1 (swine flu) virus in "[d]eveloping countries, where medical care systems are weak and supplies of antivirals insufficient." In addition to "supplying countries with diagnostic kits, medicines and masks and gloves to protect health care workers and minimize the further spread of the new virus," the WHO is continuing to distribute doses of the antiviral Tamiflu, which has been "shown to be effective so far against H1N1," according to Reuters.
Synergetics USA, Inc. a medical device company that designs, manufactures, and markets innovative devices for ophthalmic and neurosurgical applications, today announced record sales leads generated from the presentation of recently released ophthalmic products at the 2010 Annual Meeting of the American Academy of Ophthalmology (AAO). The AAO meeting was held in Chicago's McCormick Place on October 16-19, 2010.
Want to find ways that may help prevent illness naturally, for a fraction of the cost of a trip to the doctor? Interested in taking control of your health with evidence-based practices that complement conventional medicine?
Baxalta Incorporated, a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, announced today that it has submitted supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration seeking approval for the use of ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] to treat children under the age of 12 with hemophilia A and for use in surgical settings.
› Verified 7 days ago
| Entity Name | Ephraim Mcdowell Health Resource Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487708533 PECOS PAC ID: 7517876956 Enrollment ID: O20031218000776 |
News Archive
Reuters examines the WHO's battle against the H1N1 (swine flu) virus in "[d]eveloping countries, where medical care systems are weak and supplies of antivirals insufficient." In addition to "supplying countries with diagnostic kits, medicines and masks and gloves to protect health care workers and minimize the further spread of the new virus," the WHO is continuing to distribute doses of the antiviral Tamiflu, which has been "shown to be effective so far against H1N1," according to Reuters.
Synergetics USA, Inc. a medical device company that designs, manufactures, and markets innovative devices for ophthalmic and neurosurgical applications, today announced record sales leads generated from the presentation of recently released ophthalmic products at the 2010 Annual Meeting of the American Academy of Ophthalmology (AAO). The AAO meeting was held in Chicago's McCormick Place on October 16-19, 2010.
Want to find ways that may help prevent illness naturally, for a fraction of the cost of a trip to the doctor? Interested in taking control of your health with evidence-based practices that complement conventional medicine?
Baxalta Incorporated, a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, announced today that it has submitted supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration seeking approval for the use of ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] to treat children under the age of 12 with hemophilia A and for use in surgical settings.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maher Alchreiki, MD Po Box 990, Danville, KY 40423-0990 Ph: (859) 239-5870 | Maher Alchreiki, MD 216 W Walnut St, Danville, KY 40422-1858 Ph: (859) 239-5870 |
News Archive
Reuters examines the WHO's battle against the H1N1 (swine flu) virus in "[d]eveloping countries, where medical care systems are weak and supplies of antivirals insufficient." In addition to "supplying countries with diagnostic kits, medicines and masks and gloves to protect health care workers and minimize the further spread of the new virus," the WHO is continuing to distribute doses of the antiviral Tamiflu, which has been "shown to be effective so far against H1N1," according to Reuters.
Synergetics USA, Inc. a medical device company that designs, manufactures, and markets innovative devices for ophthalmic and neurosurgical applications, today announced record sales leads generated from the presentation of recently released ophthalmic products at the 2010 Annual Meeting of the American Academy of Ophthalmology (AAO). The AAO meeting was held in Chicago's McCormick Place on October 16-19, 2010.
Want to find ways that may help prevent illness naturally, for a fraction of the cost of a trip to the doctor? Interested in taking control of your health with evidence-based practices that complement conventional medicine?
Baxalta Incorporated, a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, announced today that it has submitted supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration seeking approval for the use of ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] to treat children under the age of 12 with hemophilia A and for use in surgical settings.
› Verified 7 days ago
Dr. Mark I. Brunner, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 212 S 2nd St, Danville, KY 40422 Phone: 859-236-5302 Fax: 859-236-5025 | |
Dr. Karl W Hempel, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 640 E Lexington Ave Ste B, Danville, KY 40422 Phone: 859-239-4950 Fax: 859-239-4959 | |
John S Aumiller, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 1250 Ben Ali Dr, Danville, KY 40422 Phone: 859-236-6621 Fax: 859-238-0471 | |
Hafiz I Ahmad, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1250 Ben Ali Dr, Danville, KY 40422 Phone: 859-236-6220 Fax: 859-236-6675 | |
Tory August Torma, DO Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1541 Lebanon Rd Ste 1, Danville, KY 40422 Phone: 859-236-3208 | |
David Milton Culpepper, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 212 S 2nd St, Danville, KY 40422 Phone: 859-209-2269 | |
Dr. Edgar Ruben Salas, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 216 W Walnut St, Danville, KY 40422 Phone: 859-239-5860 Fax: 859-239-5869 |